Speaker illustration

Doctor Sarah Bray

Cambridge (United Kingdom of Great Britain & Northern Ireland)

EU-Wide cross-sectional observational study of lipid-modifying therapy use in secondary and primary care: the DA VINCI study.

Event: ESC Preventive Cardiology 2022

Topic: European Association of Preventive Cardiology (EAPC)

Session: The best of EJPC 2021

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb